TET2 c.203G>A ;(p.G68E)

Variant ID: 4-106155302-G-A

NM_001127208.2(TET2):c.203G>A;(p.G68E)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.

Aging
Su, Xiaofan X; Jin, Haoxuan H; Wang, Jiaqian J; Lu, Huiping H; Gu, Tiantian T; Gao, Zhibo Z; Li, Manxiang M
Publication Date: 2022-05-25

Variant appearance in text: TET2: 203G>A
PubMed Link: 35613927
Variant Present in the following documents:
  • aging-14-204101-s004.xlsx, sheet 1
View BVdb publication page



Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib.

Oncotargets And Therapy
Cheng, Qiansong Q; Wang, Jing J; Lv, Chenglan C; Xu, Jingyan J
Publication Date: 2021

Variant appearance in text: TET2: 203G>A; Gly68Asp
PubMed Link: 34079282
Variant Present in the following documents:
  • Main text
View BVdb publication page



Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria.

The Journal Of Clinical Investigation
Shen, Wenyi W; Clemente, Michael J MJ; Hosono, Naoko N; Yoshida, Kenichi K; Przychodzen, Bartlomiej B; Yoshizato, Tetsuichi T; Shiraishi, Yuichi Y; Miyano, Satoru S; Ogawa, Seishi S; Maciejewski, Jaroslaw P JP; Makishima, Hideki H
Publication Date: 2014-10

Variant appearance in text: TET2: G68E
PubMed Link: 25244093
Variant Present in the following documents:
  • Main text
View BVdb publication page